Tenaya Therapeutics

Tenaya Therapeutics Employees

12 people indexed:

Faraz Ali

Chief Executive Officer
Jay Vora

Senior Vice President, Portfolio and Program Management
Jennifer Drimmer

General Counsel
Joanna Auch

Senior Vice President, People and Culture
Kee-Hong Kim

Chief Technology Officer
Leone Patterson

Chief Financial and Business Officer
Matthew Pollman

Senior Vice President, Clinical Development
Naymisha (Isha) Patel

Senior Vice President, Quality
Sunita Sethi

Senior Vice President, Regulatory
Timothy Hoey

Chief Scientific Officer
Whedy Wang

Senior Vice President, Biometrics
Whit Tingley

Chief Medical Officer

Tenaya Therapeutics Company Information

Tenaya Therapeutics is a biotechnology company focused on developing gene therapies and precision medicines for heart disease. Founded by leading cardiovascular scientists, the company is advancing a pipeline of investigational therapeutics for various heart conditions. Tenaya utilizes three primary product platforms: Gene Therapy, Cellular Regeneration, and Precision Medicine. The company has a dedicated in vivo pharmacology group and vivarium for disease model development, and it established the Cardiac Genetic Medicines Manufacturing Center for gene therapy production. Tenaya engages in collaborations with academic institutions such as Gladstone Institutes and the University of Texas Southwestern Medical Center. The company received FDA Orphan Drug Designation for TN-401, a treatment for PKP2-associated ARVC, and is conducting clinical trials for investigational treatments like TN-201 for MYBPC3-associated HCM and TN-401 for PKP2-associated ARVC. Additionally, Tenaya offers expanded access programs for its investigational treatments.

Report inaccurate information